Skip to content
Search

Latest Stories

GPs in deprived areas now responsible for nearly 2,500 patients each - RCGP study reveals

GPs in deprived areas now responsible for nearly 2,500 patients each - RCGP study reveals

Pharmacies have huge potential to take pressure off GPs if they are given adequate funding, says NPA CEO Paul Rees  

The Royal College of GPs (RCGP) has called on the government to increase investment in general practice, stating that they are now “seriously struggling” due to years of underfunding and neglect.

As evidence of the mounting workload pressures faced by GPs, new research published by the RCGP has revealed that GPs are now responsible for an average of 2,300 patients each.


Concerningly, the ratio has become even worse in areas of higher deprivation, where the need is greatest.

The RCGP research found that over the past six years, the average number of patients per GP in areas with the highest level of income deprivation has risen by 260, marking a 12 per cent increase—nearly double the rate observed in the least deprived areas.

In these areas, one GP is responsible for 2,450 patients, which is over 300 more patients than their counterparts in the least deprived regions.

Addressing the RCGP’s annual conference 2024 in Liverpool on Thursday, College Chair Professor Kamila Hawthorne said: “When I became a GP, it was normal to have a list size between 1,600-1,800 patients. The role was busy and challenging, but it was manageable. Our latest figures reveal that the average is now 2,300.

“This situation has become more challenging for all GP practices since 2018 and we would argue almost all are ‘under-doctored’.”

Professor Hawthorne highlighted the disparities in the GP-patient ratio, noting, "It can’t be right that a GP in Kingston upon Thames looks after 1,800 patients while a GP in Kingston upon Hull, one of the most deprived places in England, is expected to cover twice that number.”

While she praised the government for establishing a new fund of £82 million to support the hiring of GPs in substantive roles, she stressed the importance of effective implementation.

“This is a positive step, made in double-quick time, but implementation will be vital,” she said.

The RCGP is asking for increased investment in general practice, with a focus on directing more spending to areas of greatest need and enhancing initiatives to boost the number of GPs.

Professor Hawthorne called on the government to take urgent action to meet its manifesto pledge to halve the gap in healthy life expectancy between different regions of England within 10 years.

A recent ‘GP Voice’ survey conducted by the College revealed that over 40 per cent of GPs are considering leaving general practice within five years.

Paul Rees, CEO of the National Pharmacy Association (NPA), stated the RCGP’s research findings provide further evidence that “our vital primary care system is creaking at the seams.”

He noted that while GP workloads are high, pharmacies are closing at alarming rates and are unable to take up the slack.

"It's frustrating because pharmacies have huge potential to solve the problem for patients, and take pressure off GPs, if only the pain of real terms cuts over the past decade was eased,” he added.

Professor Hawthorne has welcomed Health Secretary Wes Streeting's announcement to cut GP bureaucracy in his keynote address to the RCGP annual conference on Friday.

"The Health Secretary's commitment to increase the proportion of resources going into primary care has the potential to turn things around, but this can only happen if we work together. Additional resources are needed now in general practice, and the forthcoming Budget will be the ideal opportunity to start delivering this,” she added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less